LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New AI-driven Toolkit Provides Insight into Infectious Pathogens

By LabMedica International staff writers
Posted on 20 Mar 2019
Print article
Image: The Host Response to Microbe Analysis platform can be tailored for different pathogens including Salmonella enterica (Photo courtesy of Wikipedia).
Image: The Host Response to Microbe Analysis platform can be tailored for different pathogens including Salmonella enterica (Photo courtesy of Wikipedia).
Scientists at the Francis Crick Institute (London, England) and UCL (London, England) have developed a new AI-driven platform that can analyze how pathogens infect human (‘host’) cells with the precision of a trained biologist.

The platform named HRMAn (‘Herman’), which stands for Host Response to Microbe Analysis, is open-source, easy-to-use and can be tailored for different pathogens including Salmonella enterica. HRMAn uses deep neural networks to analyze complex patterns in images of pathogen and human cell interactions, pulling out the same detailed characteristics that scientists do by-hand.

The researchers used HRMAn to analyze the body’s response to Toxoplasma gondii, a parasite that replicates in cats and is thought to be carried by more than a third of the world’s population. Researchers in the Crick’s High Throughput Screening facility collected over 30,000 microscope images of five different types of Toxoplasma-infected human cells and loaded them into HRMAn for analysis. HRMAn detected and analyzed over 175,000 pathogen-containing cellular compartments, providing detailed information about the number of parasites per cell, the location of the parasites within the cells, and how many cell proteins interacted with the parasites, among other variables. The team also used HRMAn to analyze Salmonella enterica – a bacterial pathogen 16 times smaller than Toxoplasma, demonstrating its versatility for studying different pathogens.

“What used to be a manual, time-consuming task for biologists now takes us a matter of minutes on a computer, enabling us to learn more about infectious pathogens and how our bodies respond to them, more quickly and more precisely,” said Eva Frickel, Group Leader at the Crick, who led the project. “HRMAn can actually see host-pathogen interactions like a biologist, but unlike us, it doesn’t get tired and need to sleep!”

“Using the same sorts of algorithms that run self-driving cars, we’ve created a platform that boosts the precision of high volume biological data analysis, which has revolutionized what we can do in the lab,” said Artur Yakimovich, Research Associate in Jason Mercer’s lab at the MRC LMCB at UCL and co-first author of the study. Algorithms come in handy when the platform evaluates the image-based data in a way a trained specialist would. It’s also really easy to use, even for scientists with little to no knowledge of coding.”

Related Links:
Francis Crick Institute
UCL

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.